| Struma ovarii and hyperthyroidism ( A case report ) | İdris KOÇAK,Cazip ÜSTÜN,Elif TURHAN,Mustafa TORGAÇ | 0–0 |
| Urinary excretion rates of sodium and calcium in preeclampsia | Tulin ÖZCAN,Rana YALÇINKAYA,Mete GÜNGÖR,Muammer DOĞAN,Mustafa UĞUR,Cem TURAN,Oya GÖKMEN | 115–118 |
| Serum haptoglobin levels in severe preeclampsia, eclampsia and hellp syndrome | Taşkın A. ORHAN,Cazip ÜSTÜN,Filiz F YANIK,İdris KOÇAK,Arif KÖKÇÜ | 119–122 |
| Pregnancy weight and pregnancy complications | Mehmet H. ERGENELİ,Hulusi B. ZEYNELOĞLU,Esra KUŞÇU,Hakan DURAN,Derya EROĞLU,Naciye SANDIKÇI,Mithat ERDOĞAN | 123–125 |
| Hyperandrogenism: Is it a cause for missed abortion or second trimester intrauterine fetal death? | A. Aydın ÖZSARAN,İsmail M. İTİL,Mert KAZANDI,Coşan TEREK,Eser ÖZYÜREK,Niyazi AŞKAR | 126–128 |
| Termination of pregnancy by misoprostol; Benefits and risks | Kayhan YAKIN,Ebru ÖZTÜRK,Ruşen AYTAÇ,Fırat ORTAÇ,Cihat ÜNLÜ | 129–133 |
| Evaluation of the clomiphene citrate resistance with sonography in polycytic ovarian syndrome patients | Ali Rüştü ERGÜR,A. Aktuğ ERTEKİN,Levent TÜTÜNCÜ,Ercüment MÜNGEN,Yusuf Z. YERGÖK | 134–136 |
| Ultrasound only monitoring of ovarian stimulation in IVF cycles where a long GNRH agonist protocol is used does not change the cycle outcome | L. Cem DEMİREL,Nafiye KARAKAŞ,Mete GÜNGÖR,Bora CENGİZ,Oya EVİRGEN,Ruşen AYTAÇ,Hakan SATIROĞLU,Cihat ÜNLÜ | 137–140 |
| Transvaginal ultrasound in the diagnosis of diffuse adenomyosis | İdris KOÇAK,Filiz YANIK,Cazip ÜSTÜN,Arif KÖKÇÜ | 141–142 |
| Dilatation and curettage in patients with cervical polyps: Is it necessary? | A. Aydın ÖZSARAN,İsmail M. İTİL,Sermet SAĞOL,Hakan ÇELİK,Hüseyin YILMAZ,Uçar ASENA | 143–145 |
| The reasons for intrauterine device discontinuation and subsequent contraception | Birol VURAL,FİSUN VURAL,Ahmet ERK,Onur KARABACAK | 146–148 |
| Autoimmune hemolytic anemia and pregnancy: A case report |